Measuring Alzheimer's disease progression with transition probabilities in the Taiwanese population

被引:13
作者
Fuh, JL [1 ]
Pwu, RF
Wang, SJ
Chen, YH
机构
[1] Taipei Vet Gen Hosp, Neurol Inst, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
关键词
Alzheimer's disease; transition probability; clinical dementia rating scale; dementia;
D O I
10.1002/gps.1076
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background The transition probability of Alzheimer's disease (AD) is defined as the likelihood that the disease progresses from one stage to another in a given time period. Objective To estimate the separate stage-to-stage and stage-to-death transition probabilities for Taiwanese patients with AD and to evaluate the hazard ratios of age, sex, behavioral symptoms, and medications on disease progression. Method We examined data (severity of dementia, hallucinations or delusions, use of cholinesterase inhibitors [CEIs], survival) in 365 patients with probable AD at baseline and at follow-up (mean +/- SD 29 +/- 117 months, range 3-109 months). Results Modified survival analysis revealed that transition probabilities of Taiwanese patients were similar to those of Western patients. The probability of dementia remaining at the same stage was higher in patients taking CEIs than in other. Men had a higher probability of dying in the mild stage. Conclusion Transition probabilities can be used to measure AD progression. CEIs used to treat AD might alter the disease course. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:266 / 270
页数:5
相关论文
共 15 条
[1]   Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression [J].
Farlow, MR ;
Hake, A ;
Messina, J ;
Hartman, R ;
Veach, J ;
Anand, R .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :417-422
[2]   The consortium to establish a registry for Alzheimer's disease (CERAD) .14. Demographic and clinical predictors of survival in patients with Alzheimer's [J].
Heyman, A ;
Peterson, B ;
Fillenbaum, G ;
Pieper, C .
NEUROLOGY, 1996, 46 (03) :656-660
[3]   Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality [J].
Knopman, D ;
Schneider, L ;
Davis, K ;
Talwalker, S ;
Smith, F ;
Hoover, T ;
Gracon, S ;
Apter, JT ;
Barnett, M ;
Baumel, B ;
Eisner, LS ;
Bennett, D ;
Forchetti, C ;
Blass, JP ;
Borison, RL ;
Celesia, GG ;
Dexter, J ;
Doody, R ;
DuBoff, EA ;
Earl, NL ;
Farlow, M ;
Hendrie, HC ;
Farmer, M ;
Ferguson, J ;
Foster, NL ;
Greenwald, M ;
Groenendyk, A ;
Jurkowski, C ;
Katz, I ;
Prodner, CK ;
Knopman, DS ;
Margolin, RA ;
Morris, JC ;
Rubin, EH ;
Reyes, PF ;
Rymer, MM ;
Sadowsky, CH ;
Pawluczyk, S ;
Smith, WT ;
Solomon, PR ;
Pendlebury, WW ;
Taylor, J ;
Thein, SG ;
Tuttle, P ;
Tyndall, RJ .
NEUROLOGY, 1996, 47 (01) :166-177
[4]  
Liu CK, 1996, J FORMOS MED ASSOC, V95, P762
[5]   ASSESSING COGNITIVE-ABILITIES AND DEMENTIA IN A PREDOMINANTLY ILLITERATE POPULATION OF OLDER INDIVIDUALS IN KINMEN [J].
LIU, HC ;
CHOU, P ;
LIN, KN ;
WANG, SJ ;
FUH, JL ;
LIN, HC ;
LIU, CY ;
WU, GS ;
LARSON, EB ;
WHITE, LR ;
GRAVES, AB ;
TENG, EL .
PSYCHOLOGICAL MEDICINE, 1994, 24 (03) :763-770
[6]   PREVALENCE AND SUBTYPES OF DEMENTIA IN TAIWAN - A COMMUNITY SURVEY OF 5297 INDIVIDUALS [J].
LIU, HC ;
LIN, KN ;
TENG, EL ;
WANG, SJ ;
FUH, JL ;
GUO, NW ;
CHOU, P ;
HU, HH ;
CHIANG, BN .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1995, 43 (02) :144-149
[7]   Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease [J].
Lopez, OL ;
Becker, JT ;
Wisniewski, S ;
Saxton, J ;
Kaufer, DI ;
Dekosky, ST .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (03) :310-314
[8]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[9]   A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients [J].
Mohs, RC ;
Doody, RS ;
Morris, JC ;
Ieni, JR ;
Rogers, SL ;
Perdomo, CA ;
Pratt, RD .
NEUROLOGY, 2001, 57 (03) :481-488
[10]   THE CLINICAL DEMENTIA RATING (CDR) - CURRENT VERSION AND SCORING RULES [J].
MORRIS, JC .
NEUROLOGY, 1993, 43 (11) :2412-2414